Overview FDA Perspective

Risk Based Cleaning, Sanitization, and Sterilization Michael Klapal, Drug Specialist U.S. FDA March 27, 2012 M. Klapal M. Klapal -- FDA PerspectiveFDA Perspective NJ Chapter PDA Meeting April 2012 1 Office of Regulatory Affairs New Jersey District Office Overview FDA Perspective Federal Food, Drug, and Cosmetic Act Regulations (21 CFR 210 & 211 ...


Loved it? Download it, Share it!!
Share

Preview 2

Image

Preview 3

Image

Preview 4

Image

Preview 5

Image

Preview 6

Image

Thumbnails


Image
Image